Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers.

Wallis, Robert S; Maeurer, Markus; Mwaba, Peter; Chakaya, Jeremiah; Rustomjee, Roxana; Migliori, Giovanni Battista; Marais, Ben; Schito, Marco; Churchyard, Gavin; Swaminathan, Soumya; +2 more... Hoelscher, Michael; Zumla, Alimuddin; (2016) Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. The Lancet infectious diseases, 16 (4). e34-e46. ISSN 1473-3099 DOI: https://doi.org/10.1016/S1473-3099(16)00070-0

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S1473-3099(16)00070-0

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar